Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 4:05 PM View:  | Mohanty Aditya P. Chief Executive Officer | Biora Therapeutics, Inc. (BIOR) | 15-Feb-24 | Grant | 819,000 | -- | -- | 114% 720.49K to 1.54M | |
| 15-Feb-24 4:05 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Feb-24 | Grant | 230,000 | -- | -- | 88% 262.19K to 492.19K | |
| 15-Feb-24 4:05 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Feb-24 | Grant | 325,000 | -- | -- | 117% 278.66K to 603.66K | |
| 19-Sep-23 4:15 PM View: | Athyrium Opportunities III ... Director 10% Owner | Biora Therapeutics, Inc. (BIOR) | 18-Sep-23 | Grant | 9,235,280 | -- | -- | 545% 1.69M to 10.93M | |
| 17-Aug-23 4:21 PM View: | Mohanty Aditya P. Chief Executive Officer Director | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Grant | 559,450 | -- | -- | 201% 278.92K to 838.37K | |
| 17-Aug-23 4:22 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Payment of Exercise | 40,022 | $3.14 | $125,669.00 | (13%) 318.68K to 278.66K | |
| 17-Aug-23 4:27 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Grant | 210,175 | -- | -- | 238% 88.2K to 298.38K | |
| 17-Aug-23 4:21 PM View: | Mohanty Aditya P. Chief Executive Officer Director | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Payment of Exercise | 117,881 | $3.14 | $370,146.00 | (14%) 838.37K to 720.49K | |
| 17-Aug-23 4:22 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Grant | 219,650 | -- | -- | 222% 99.03K to 318.68K | |
| 17-Aug-23 4:27 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Payment of Exercise | 36,183 | $3.14 | $113,615.00 | (12%) 298.38K to 262.19K | |
| 16-Jun-23 4:06 PM View: | Powell Lynne Director | Biora Therapeutics, Inc. (BIOR) | 14-Jun-23 | Grant | 12,500 | -- | -- | 218% 5.75K to 18.25K | |
| 16-Jun-23 4:07 PM View: | Kotzin Brian L. Director | Biora Therapeutics, Inc. (BIOR) | 14-Jun-23 | Grant | 12,500 | -- | -- | 218% 5.75K to 18.25K | |
| 16-Jun-23 4:05 PM View: | Alter Jeffrey D. Director | Biora Therapeutics, Inc. (BIOR) | 14-Jun-23 | Grant | 12,500 | -- | -- | 191% 6.55K to 19.05K | |
| 16-Jun-23 4:05 PM View: | Howe Jill Ann Director | Biora Therapeutics, Inc. (BIOR) | 14-Jun-23 | Grant | 12,500 | -- | -- | 181% 6.92K to 19.42K | |
| 17-May-23 4:55 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-May-23 | Payment of Exercise | 2,368 | $3.35 | $7,932.80 | (3%) 90.57K to 88.2K | |
| 17-May-23 4:54 PM View: | Mohanty Aditya P. Chief Executive Officer | Biora Therapeutics, Inc. (BIOR) | 15-May-23 | Payment of Exercise | 11,249 | $3.35 | $37,684.10 | (4%) 290.17K to 278.92K | |
| 17-May-23 4:56 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-May-23 | Payment of Exercise | 2,807 | $3.35 | $9,403.45 | (3%) 101.84K to 99.03K | |
| 17-Mar-23 9:16 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Payment of Exercise | 11,216 | $2.56 | $28,713.00 | (10%) 113.06K to 101.84K | |
| 17-Mar-23 9:21 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Grant | 79,634 | -- | -- | 368% 21.62K to 101.25K | |
| 17-Mar-23 9:21 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Payment of Exercise | 10,683 | $2.56 | $27,348.50 | (11%) 101.25K to 90.57K | |
| 17-Mar-23 9:18 PM View: | Mohanty Aditya P. Chief Executive Officer Director | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Grant | 200,429 | -- | -- | 179% 112.0K to 312.42K | |
| 17-Mar-23 9:18 PM View: | Mohanty Aditya P. Chief Executive Officer Director | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Payment of Exercise | 22,252 | $2.56 | $56,965.10 | (7%) 312.42K to 290.17K | |
| 17-Mar-23 9:16 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Grant | 84,917 | -- | -- | 302% 28.14K to 113.06K | |
| 17-Feb-23 4:15 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Feb-23 | Payment of Exercise | 84 | $3.46 | $290.64 | (< 1%) 21.7K to 21.62K | |
| 17-Feb-23 4:15 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Feb-23 | Payment of Exercise | 269 | $3.46 | $930.74 | (< 1%) 28.41K to 28.14K | |
| 05-Jan-23 4:05 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 44 | -- | -- | (100%) 44 to 0 | |
| 05-Jan-23 4:06 PM View: | Kotzin Brian L. Director | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 44 | -- | -- | (100%) 44 to 0 | |
| 05-Jan-23 4:05 PM View: | Sarna Surbhi Director | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 8 | -- | -- | (100%) 8 to 0 | |
| 05-Jan-23 4:06 PM View: | Mohanty Aditya P. Chief Executive Officer Director | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 178 | -- | -- | (100%) 0.18K to 0 | |
| 05-Jan-23 4:05 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 95 | -- | -- | (100%) 95 to 0 | |
| 05-Jan-23 4:05 PM View: | Alter Jeffrey D. Director | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 65 | -- | -- | (100%) 65 to 0 | |
| 05-Jan-23 4:05 PM View: | Howe Jill Ann Director | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 19 | -- | -- | (100%) 19 to 0 | |
| 05-Jan-23 4:05 PM View: | Powell Lynne Director | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 45 | -- | -- | (100%) 45 to 0 | |
| 05-Jan-23 4:55 PM View: | Athyrium Opportunities III ... 10% Owner | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 42,362 | -- | -- | (100%) 42.36K to 0 | |
| 16-Nov-22 9:49 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Nov-22 | Payment of Exercise | 4,529 | $0.27 | $1,222.83 | (< 1%) 546.93K to 542.4K | |
| 16-Nov-22 9:48 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Nov-22 | Payment of Exercise | 5,194 | $0.27 | $1,402.38 | (< 1%) 715.32K to 710.12K | |
| 16-Nov-22 9:48 PM View: | Mohanty Aditya P. Chief Executive Officer Director | Biora Therapeutics, Inc. (BIOR) | 15-Nov-22 | Payment of Exercise | 175,071 | $0.27 | $47,269.20 | (6%) 2.97M to 2.8M | |
| 14-Nov-22 4:30 PM View: | Athyrium Opportunities III ... 10% Owner | Biora Therapeutics, Inc. (BIOR) | 09-Nov-22 | Purchase | 12,506,200 | -- | -- | 42% 29.86M to 42.36M | |
| 16-Aug-22 5:58 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-Aug-22 | Payment of Exercise | 5,952 | $1.04 | $6,190.08 | (< 1%) 714.38K to 708.43K | |
| 16-Aug-22 6:02 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-Aug-22 | Payment of Exercise | 1,355 | $1.04 | $1,409.20 | (< 1%) 548.28K to 546.93K | |
| 05-Jul-22 6:48 PM View: | Sarna Surbhi Director | Biora Therapeutics, Inc. (BIOR) | 05-Jul-22 | Sale | 7,517 | $0.61 | $4,585.37 | (5%) 156.29K to 148.77K | |
| 17-Jun-22 4:30 PM View: | Alter Jeffrey D. Director | Biora Therapeutics, Inc. (BIOR) | 15-Jun-22 | Grant | 96,154 | -- | -- | 142% 67.52K to 163.67K | |
| 17-Jun-22 4:31 PM View: | Howe Jill Ann Director | Biora Therapeutics, Inc. (BIOR) | 15-Jun-22 | Grant | 96,154 | -- | -- | 125% 76.75K to 172.91K | |
| 17-Jun-22 4:30 PM View: | Powell Lynne Director | Biora Therapeutics, Inc. (BIOR) | 15-Jun-22 | Grant | 96,154 | -- | -- | 202% 47.52K to 143.67K | |
| 17-Jun-22 4:31 PM View: | Kotzin Brian L. Director | Biora Therapeutics, Inc. (BIOR) | 15-Jun-22 | Grant | 96,154 | -- | -- | 202% 47.52K to 143.67K | |
| 17-Jun-22 4:30 PM View: | Sarna Surbhi Director | Biora Therapeutics, Inc. (BIOR) | 15-Jun-22 | Grant | 96,154 | -- | -- | 160% 60.14K to 156.29K | |
| 17-May-22 5:27 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-May-22 | Grant | 239,962 | -- | -- | 76% 316.63K to 556.59K | |
| 17-May-22 5:27 PM View: | Neumann Clarke See Remarks | Biora Therapeutics, Inc. (BIOR) | 15-May-22 | Payment of Exercise | 8,305 | $0.75 | $6,228.75 | (1%) 556.59K to 548.28K | |
| 17-May-22 5:19 PM View: | Mohanty Aditya P. Chief Executive Officer Director | Biora Therapeutics, Inc. (BIOR) | 15-May-22 | Grant | 1,562,500 | -- | -- | 111% 1.41M to 2.97M | |
| 17-May-22 5:18 PM View: | Desparbes Eric Chief Financial Officer | Biora Therapeutics, Inc. (BIOR) | 15-May-22 | Grant | 292,406 | -- | -- | 69% 423.17K to 715.58K |
